Cargando…

FSIP1 Is Associated with Poor Prognosis and Can Be Used to Construct a Prognostic Model in Gastric Cancer

Gastric cancer (GC) is one of the most common upper gastrointestinal malignant tumors, and the incidence of the GC shows an increasing trend in the past years. Finding more sensitive markers will help to reveal the mechanism of GC progression and clinic diagnoses. This study first analyzed the mRNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Xiuchun, Dai, Junzhu, Han, Ying, You, Qi, Liu, Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187450/ https://www.ncbi.nlm.nih.gov/pubmed/35692888 http://dx.doi.org/10.1155/2022/2478551

Ejemplares similares

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

Expression and clinicopathological significance of FSIP1 in breast cancer
por: Zhang, Hao, et al.
Publicado: (2015)

Bi-allelic mutation in Fsip1 impairs acrosome vesicle formation and attenuates flagellogenesis in mice
por: Gamallat, Yaser, et al.
Publicado: (2021)

Novel FSIP2 Variants Induce Super-Length Mitochondrial Sheath and Asthenoteratozoospermia in Humans
por: Lv, Mingrong, et al.
Publicado: (2023)

Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization
por: Yan, Meisi, et al.
Publicado: (2019)

Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma
por: Ying, Haoxuan, et al.
Publicado: (2021)

Positive Association between Aspirin-Intolerant Asthma and Genetic Polymorphisms of FSIP1: a Case-Case Study
por: Kim, Jason Yongha, et al.
Publicado: (2010)

MMP16 is a marker of poor prognosis in gastric cancer promoting proliferation and invasion
por: Cao, Li, et al.
Publicado: (2016)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
por: He, Jun, et al.
Publicado: (2016)

PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
por: Li, Xinwei, et al.
Publicado: (2022)

Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2021)

Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer
por: Jiang, Xiaotao, et al.
Publicado: (2021)

LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2020)

Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer
por: Li, Ying, et al.
Publicado: (2020)

Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2023)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer
por: Shi, Jing, et al.
Publicado: (2012)

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
por: Han, Deng, et al.
Publicado: (2021)

Overexpression of MMP21 and MMP28 is associated with gastric cancer progression and poor prognosis
por: Zhang, Jizhen, et al.
Publicado: (2018)

Constructing a new prognostic signature of gastric cancer based on multiple data sets
por: Zhou, Liqiang, et al.
Publicado: (2021)

Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Trop2 is overexpressed in gastric cancer and predicts poor prognosis
por: Zhao, Wei, et al.
Publicado: (2015)

High expression of VCAN is an independent predictor of poor prognosis in gastric cancer
por: Li, Wenfei, et al.
Publicado: (2020)

Immune-Related LncRNAs to Construct a Prognosis Risk-Assessment Model for Gastric Cancer
por: Zhi, Shilin, et al.
Publicado: (2022)

PRDX4 overexpression is associated with poor prognosis in gastric cancer
por: Park, Sun Yi, et al.
Publicado: (2020)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

Postoperative fever predicts poor prognosis of gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis
por: Huang, Chao, et al.
Publicado: (2020)

Expression of LOX Suggests Poor Prognosis in Gastric Cancer
por: Zhu, Jinfeng, et al.
Publicado: (2021)

Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
por: Xian, Yun, et al.
Publicado: (2016)

High expression of GMⅡ is associated with poor prognosis of gastric cancer patients
por: Zhu, Shasha, et al.
Publicado: (2019)

Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
por: Ling, Zhi-Qiang, et al.
Publicado: (2013)

Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer
por: Xia, Shujing, et al.
Publicado: (2019)

Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis
por: Xu, Li-pu, et al.
Publicado: (2020)

High expression of PIG11 correlates with poor prognosis in gastric cancer
por: Gu, Juan, et al.
Publicado: (2021)

Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer
por: Cheng, Anqi, et al.
Publicado: (2021)

Integrating 13 Microarrays to Construct a 6 RNA-binding proteins Prognostic Signature for Gastric Cancer patients
por: Zhou, Liqiang, et al.
Publicado: (2021)

MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial–Mesenchymal Transition In Gastric Cancer
por: Li, Taiyuan, et al.
Publicado: (2019)

Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer
por: Wu, Yijun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vnphe29etd7ft5ct2gp38ld91o